“Right of First Refusal and

Co-Sale Agreement”

DEFINITIONS

the ninth amended and restated right of first refusal and
co-sale agreement entered into on June 1, 2018 by and
among the Company, LC Fund, LC Parallel Fund, Cheng
Yu Investments, LC Healthcare, Highsino, TLS Beta,
Hillhouse INOV, Cowin China, F-Prime Capital, Asia
Ventures, Lilly Asia, LAV Opus Limited, LAV Agility
Limited, Life Sciences, Suzhou Industrial Park, Suzhou
Frontline, Hua Yuan, Future Industry, Pingan Inno
Limited, Easy Swift Limited, CBC, Shanghai Sa Wang,
China Life, Shanghai Pengfang, Shanghai Chiyi, Xiangan
Inno Limited, Seacliff (Cayman) Ltd., Dwyer (Cayman)
Ltd., Scott Matthew Wheelwright, Zheng Jia, De-Chao
Michael Yu, Charles Leland Cooney, Taikang AMC HK,
Cormorant
Private Healthcare, Cormorant Global
Healthcare, CMRA, Rock Springs, CRF Investment and
Ally Bridge

“RMB” or “Renminbi”

Renminbi, the lawful currency of China

“Rock Springs”

“RS Plan”

Rock Springs Capital Master Fund LP, an exempted
limited partnership registered under
the Exempted
Limited Partnership Law (as amended) of the Cayman
Islands on July 25, 2013 and one of our Pre-IPO Investors

the restricted share plan adopted by the Company on
October 15, 2018, the principal terms of which are set out
in the section headed “Statutory and General Information
– Equity Plans – RS Plan” in Appendix IV

“Rule 144A”

Rule 144A under the U.S. Securities Act

“SAFE”

“SEC”

the State Administration of Foreign Exchange of the PRC

the Securities and Exchange Commission of the United
States

“Series A Preferred Shareholders”

the holder of the Series A Preferred Shares

– 31 –

